Two drug-coated stent firms suffer setback
This article was originally published in Clinica
Executive Summary
Guidant and Biocompatibles International, which are racing to develop drug-coated stents for treating restenosis, have endured setbacks after both firms halted human trials of their respective products due to poor early results.